The first fiber chromatographic clarification solution to remove both small insoluble and soluble contaminants.
Have small soluble contaminants such as DNA and HCP created purification challenges for your downstream process? The solution: 3M™ Emphaze™ AEX Hybrid Purifier is designed to address these challenges and also to deliver consistent, high-purity clarified process fluid and to further enhance the performance of Protein A capture column.
3M™ Emphaze™ AEX Hybrid Purifier can be easily incorporated into clarification without changing your current process, in a scalable fashion, and can provide a more efficient process from end to end. It can also replace the second stage of depth filtration.
Product recovery can be substantially increased by reducing the sterilising membrane surface area pre-Protein A, eliminating the post-viral inactivation depth filter clarification requirement and combining polishing trains into one connected operation.
By introducing a fiber chromatographic solutions in your process, you can achieve:
Implementation of 3M™ Emphaze™ AEX Hybrid Purifier during mAb clarification process can substantially enhance purification performance of the Protein A column by significantly reducing DNA and HCP load. In addition, clarification with Emphaze AEX hybrid purifier in conjunction with Protein A chromatography may reduce HCPs that are known to persist through the polishing train. Integration of Emphaze AEX hybrid purifier in the clarification stage may simplify mAb purification by reducing multiple types of impurities in a single process step, leading to better process economics.
Read application data for endotoxin removal from protein solutions using 3M™ Emphaze™ AEX Hybrid Purifier - A robust and simple solution to the challenging problem of endotoxin removal to help accelerate the preclinical development of biopharmaceutical drug candidates.
3M™ Emphaze™ AEX Hybrid Purifier is ideal for endotoxin removal applications in a laboratory setting, especially for high throughput processing of protein samples for screening during pre-clinical and early-stage clinical testing. The high capacity of 3M™ Emphaze™ AEX Hybrid Purifier allows for high protein loads, and scalable products allow for easy transition to pilot or production scale processes.
Technology Platforms
|
MechanismAEX |
MaterialsSynthetic |
Feed StreamDirect harvest |
ScalabilityLinear scalability from lab to multi-capsule commercial production |
Applications
|
Features
|
Technology Platforms
|
MechanismAEX |
MaterialsSynthetic |
Feed StreamPost depth filter, post centrifuge |
ScalabilityLinear scalability from lab to multi-capsule commercial production |
Applications
|
Features
|
Innovation in cell culture production has created additional complexities for the clarification process. 3M offers single-stage and single-use solutions to help simplify your process and increase manufacturing efficiency.
Fill out this form for any technical or process-related question, and an appropriate 3M Biopharmaceutical representative will contact you to answer your question or direct your request.
Find solutions for process-related impurities leveraging membrane and chromatography technology.
Find solutions for more efficient bioprocessing across our portfolio.
One step can transform your mAb and recombinant protein manufacturing process. At 3M, we’re helping build better, more efficient and simpler manufacturing processes by developing solutions to enhance biologic drug recovery that leads to improved process economics.
Gene therapy is a fast-changing, promising field with new challenges for manufacturing and separation. Learn how we can help with our technologies and expertise.
Plasma fractionation has existed for decades, but additional separation methods are becoming increasingly common. We offer a range of products to help you with your process.
If you need solutions for catalyst removal and recovery, colour removal, particulate filtration and fill-finish, 3M offers a wide range of adsorptive depth filters and membrane products for application in the chemical pharmaceutical manufacturing.